Blue Chip Venture Company

Portfolio · 1

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

1 round $70.0M committed Latest: 2015-02

Investment activity

1 portfolio exit on record.

Q&A

What is Blue Chip Venture Company's primary sector focus?

Blue Chip Venture Company has a focus on the Health Tech & Life Sciences sector, as evidenced by its portfolio company Chiasma and its exits.

Can you name a notable portfolio company of Blue Chip Venture Company?

A notable portfolio company of Blue Chip Venture Company is Chiasma, which focuses on oral therapeutic options for patients with rare diseases.

What is Blue Chip Venture Company's exit history?

Blue Chip Venture Company had an exit in July 2015 when its portfolio company Chiasma went public on NASDAQ with a valuation of $562M.

What was the last recorded investment stage for Blue Chip Venture Company?

The last recorded investment stage for Blue Chip Venture Company was an E Round in February 2015.

What is the total capital raised by Blue Chip Venture Company's exited company, Chiasma, prior to its IPO?

Chiasma, a portfolio company of Blue Chip Venture Company that went public, raised $102M in capital prior to its IPO.